SCHEMBL9071474

SCHEMBL9071474

CC(C)COc1cc(OC(C)C)cc(C(N)=O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GCK P35557 5/20 0.53
▸ RARA P10276 1/20 0.53
▸ RARB P10826 1/20 0.53
▸ RARG P13631 1/20 0.53
▸ PARP10 Q53GL7 1/20 0.51
▸ NR1H4 Q96RI1 3/20 0.41
▸ PLAU P00749 2/20 0.40
▸ SIRT2 Q8IXJ6 1/20 0.40
▸ F2 P00734 1/20 0.40
▸ PLG P00747 1/20 0.40
▸ PLAT P00750 1/20 0.40
▸ KLKB1 P03952 1/20 0.40
▸ PRSS1 P07477 1/20 0.40
▸ GRIN2D O15399 1/20 0.39
▸ GRIN3B O60391 1/20 0.39
▸ GRIN1 Q05586 1/20 0.39
▸ GRIN2A Q12879 1/20 0.39
▸ GRIN2B Q13224 1/20 0.39
▸ GRIN2C Q14957 1/20 0.39
▸ GRIN3A Q8TCU5 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2666400 0.88 PARP10 (0.49) GCKRARARARBRARGPARP10
SCHEMBL14017929 0.87 PARP10 (0.47) GCKRARARARBRARGPARP10
SCHEMBL9071440 0.83 PARP10 (0.50) GCKPARP10PLAUF2PLG
SCHEMBL13704013 0.83 PARP10 (0.44) GCKRARARARBRARGPARP10
SCHEMBL16950335 0.82 GCK (0.50) GCKRARARARBRARGNR1H4
SCHEMBL9071442 0.81 PARP10 (0.47) GCKRARARARBRARGPARP10
SCHEMBL14092358 0.81 GCK (0.50) GCKRARARARBRARGNR1H4
SCHEMBL14018037 0.81 PARP10 (0.47) GCKRARARARBRARGPARP10
SCHEMBL14018622 0.80 PARP10 (0.56) GCKPARP10NR1H4IRAK4ACACB
SCHEMBL9071441 0.79 PARP10 (0.53) PARP10PLAUF2PLGPLAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1529530-B3 Compounds affecting glucokinase ASTRAZENECA AB (SE) 2009-09-02 — — EP disclosed
EP-1987831-A1 COMPOUNDS EFFECTING GLUCOKINASE AstraZeneca AB (SE) 2008-11-05 — — EP disclosed
EP-1669068-B1 Compounds effecting Glucokinase ASTRAZENECA AB (SE) 2008-06-11 — — EP disclosed
EP-1674097-B1 Compounds effecting glucokinase ASTRAZENECA AB (SE) 2008-06-11 — — EP disclosed
EP-1661567-B1 Compounds effecting Glucokinase ASTRAZENECA AB (SE) 2008-06-11 — — EP disclosed
EP-1568367-B1 Compounds effecting glucokinase ASTRAZENECA AB (SE) 2007-04-18 — — EP disclosed
WO-2003015774-A1 COMPOUNDS EFFECTING GLUCOKINASE ASTRAZENECA AB (SE) 2003-02-27 — — WO disclosed
Send feedback